{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:51:27Z","timestamp":1774623087756,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza viruses cause pneumonia in approximately one-third of cases, and pneumonia is an important cause of death. The aim was to identify risk factors associated with severity and those that could predict the development of pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, observational study included all adult patients with confirmed influenza virus infection admitted to Son Espases University Hospital during four influenza seasons in Spain (October to May) from to 2012\u20132016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 666 patients with laboratory-confirmed influenza were included, 93 (14%) of which were severe; 73 (10.9%) were admitted to Intensive Care Unit (ICU), 39 (5.8%) died, and 185 (27.7%) developed pneumonia. Compared to less severe cases, patients with severe disease: were less vaccinated (40% vs. 28%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021); presented with more confusion (26.9% vs. 6.8%), were more hypoxemic (Horowitz index (PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ) 261 vs. 280), had higher C-reactive protein (CRP) (12.3 vs. 4.0), had more coinfections (26.8% vs. 6.3%) and had more pleural effusion (14% vs. 2.6%) (last six all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Risk factors significantly associated with severity were pneumonia [OR (95% CI)\u2009=\u20094.14 (2.4\u20137.16)], history of heart disease (1.84, 1.03\u20133.28), and confusion at admission (4.99, 2.55\u20139.74). Influenza vaccination was protective (0.53, 0.28\u20130.98). Compared to those without pneumonia, the pneumonia group had higher CRP (11.3 vs. 4.0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), lower oxygen saturation (92% vs. 94%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), were more hypoxic (PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      266 vs. 281,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and incurred more mechanical ventilation, septic shock, admission to the ICU, and deaths (all four\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Higher CRP and lower oxygen saturation were independent variables for predicting the development of pneumonia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pneumonia, history of heart disease, confusion and no influenza vaccination were independent variables to present complications in patients admitted with influenza infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09173-8","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T04:02:03Z","timestamp":1710216123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of viral pneumonia and risk factors associated with severity of influenza virus infection in hospitalized patients from 2012 to 2016"],"prefix":"10.1186","volume":"24","author":[{"given":"M. I.","family":"Fullana Barcel\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Artigues Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Millan Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Asensio Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferre Beltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"del Carmen Lopez Bilbao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Reina Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Riera Jaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"9173_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1004-y","volume":"15","author":"S Garg","year":"2015","unstructured":"Garg S, Jain S, Dawood FS, Jhung M, P\u00e9rez A, D\u2019Mello T, et al. Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005\u20132008. BMC Infect Dis. 2015;15:1\u20139. https:\/\/doi.org\/10.1186\/s12879-015-1004-y.","journal-title":"BMC Infect Dis"},{"key":"9173_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/jim-2018-000712","volume":"66","author":"D Dandachi","year":"2018","unstructured":"Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med. 2018;66:957\u201365. https:\/\/doi.org\/10.1136\/jim-2018-000712.","journal-title":"J Investig Med"},{"key":"9173_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1\u201317. https:\/\/doi.org\/10.3389\/fmicb.2017.01041.","journal-title":"Front Microbiol"},{"key":"9173_CR4","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/j.ijid.2012.01.003","volume":"16","author":"ML Metersky","year":"2012","unstructured":"Metersky ML, Masterton RG, Lode H, File TM, Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16:e321\u201331. https:\/\/doi.org\/10.1016\/j.ijid.2012.01.003.","journal-title":"Int J Infect Dis"},{"key":"9173_CR5","doi-asserted-by":"publisher","unstructured":"Bello S, Minchol\u00e9 E, Fandos S, Lasierra AB, Ruiz MA, Simon AL, et al. Inflammatory response in mixed viral-bacterial community-acquired pneumonia. BMC Pulm Med. 2014;14. https:\/\/doi.org\/10.1186\/1471-2466-14-123.","DOI":"10.1186\/1471-2466-14-123"},{"key":"9173_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/rmed.1999.0774","volume":"94","author":"A Ruiz-Gonz\u00e1lez","year":"2000","unstructured":"Ruiz-Gonz\u00e1lez A, Falguera M, Vives M, Nogu\u00e9s A, Porcel JM, Rubio-Caballero M. Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology. Respir Med. 2000;94:505\u201310. https:\/\/doi.org\/10.1053\/rmed.1999.0774.","journal-title":"Respir Med"},{"key":"9173_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/ggi.12036","volume":"13","author":"HM Ma","year":"2013","unstructured":"Ma HM, Lee KP, Woo J. Predictors of viral pneumonia: the need for viral testing in all patients hospitalized for nursing home-acquired pneumonia. Geriatr Gerontol Int. 2013;13:949\u201357. https:\/\/doi.org\/10.1111\/ggi.12036.","journal-title":"Geriatr Gerontol Int"},{"key":"9173_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377:1264\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(10)61459-6.","journal-title":"Lancet"},{"key":"9173_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcv.2016.04.005","volume":"79","author":"P Loubet","year":"2016","unstructured":"Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study. J Clin Virol. 2016;79:68\u201373. https:\/\/doi.org\/10.1016\/j.jcv.2016.04.005.","journal-title":"J Clin Virol"},{"key":"9173_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0210353","volume":"14","author":"A Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez A, Soldevila N, Romero-Tamarit A, Torner N, Godoy P, Rius C, et al. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype. PLoS ONE. 2019;14:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0210353.","journal-title":"PLoS ONE"},{"key":"9173_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jcrc.2018.11.013","volume":"50","author":"MC Beumer","year":"2019","unstructured":"Beumer MC, Koch RM, Beuningen D, Van, Oudelashof AM, Veerdonk FL, Van De, Kolwijck E. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59\u201365.","journal-title":"J Crit Care"},{"key":"9173_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ccc.2013.06.003","volume":"29","author":"CD Ramsey","year":"2013","unstructured":"Ramsey CD, Kumar A. Influenza and endemic viral pneumonia. Crit Care Clin. 2013;29:1069\u201386. https:\/\/doi.org\/10.1016\/j.ccc.2013.06.003.","journal-title":"Crit Care Clin"},{"key":"9173_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijid.2020.01.017","volume":"92","author":"Q Zou","year":"2020","unstructured":"Zou Q, Zheng S, Wang X, Liu S, Bao J, Yu F, et al. Influenza A-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments. Int J Infect Dis. 2020;92:208\u201313. https:\/\/doi.org\/10.1016\/j.ijid.2020.01.017.","journal-title":"Int J Infect Dis"},{"key":"9173_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10096-016-2833-3","volume":"36","author":"B Hermann","year":"2017","unstructured":"Hermann B, Lehners N, Brodhun M, Boden K, Hochhaus A, Kochanek M, et al. Influenza virus infections in patients with malignancies\u2013\u2013 characteristics and outcome of the season 2014\/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis. 2017;36:565\u201373. https:\/\/doi.org\/10.1007\/s10096-016-2833-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9173_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/cit194","volume":"57","author":"J Castilla","year":"2013","unstructured":"Castilla J, Godoy P, Dom\u00ednguez \u00c1, Mart\u00ednez-Baz I, Astray J, Mart\u00edn V, et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013;57:167\u201375. https:\/\/doi.org\/10.1093\/cid\/cit194.","journal-title":"Clin Infect Dis"},{"key":"9173_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1378\/chest.14-2768","volume":"149","author":"T Maruyama","year":"2016","unstructured":"Maruyama T, Fujisawa T, Suga S, Nakamura H, Nagao M, Taniguchi K, et al. Outcomes and prognostic features of patients with influenza requiring hospitalization and receiving early antiviral therapy: a prospective multicenter cohort study. Chest. 2016;149:526\u201334. https:\/\/doi.org\/10.1378\/chest.14-2768.","journal-title":"Chest"},{"key":"9173_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jinf.2013.05.006","volume":"67","author":"D Viasus","year":"2013","unstructured":"Viasus D, Marinescu C, Villoslada A, Gracia-ahufinger I, Fern A, Ortega L, et al. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect. 2013;67:185\u201393.","journal-title":"J Infect"},{"key":"9173_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/thx.2010.151522","volume":"66","author":"T Bewick","year":"2011","unstructured":"Bewick T, Myles P, Greenwood S, Nguyen-Van-Tam JS, Brett SJ, Semple MG, et al. Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax. 2011;66:247\u201352. https:\/\/doi.org\/10.1136\/thx.2010.151522.","journal-title":"Thorax"},{"key":"9173_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1172\/jci103791","volume":"38","author":"DB LOURIA","year":"1959","unstructured":"Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957\u20131958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213\u201365. https:\/\/doi.org\/10.1172\/jci103791.","journal-title":"J Clin Invest"},{"key":"9173_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/cir050","volume":"52","author":"DN Gilbert","year":"2011","unstructured":"Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011;52:346\u201350. https:\/\/doi.org\/10.1093\/cid\/cir050.","journal-title":"Clin Infect Dis"},{"key":"9173_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3109\/00365548.2014.945955","volume":"46","author":"N Johansson","year":"2014","unstructured":"Johansson N, Kalin M, Backman-Johansson C, Larsson A, Nilsson K, Hedlund J. Procalcitonin levels in community-acquired pneumonia-correlation with aetiology and severity. Scand J Infect Dis. 2014;46:787\u201391. https:\/\/doi.org\/10.3109\/00365548.2014.945955.","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"9173_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.arbres.2015.02.015","volume":"51","author":"JM Galv\u00e1n","year":"2015","unstructured":"Galv\u00e1n JM, Rajas O, Aspa J. Review of non-bacterial infections in Respiratory Medicine: viral pneumonia. Arch Bronconeumol. 2015;51(11):590\u20137.","journal-title":"Arch Bronconeumol"},{"key":"9173_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s15010-021-01615-8","volume":"49","author":"I Pink","year":"2021","unstructured":"Pink I, Raupach D, Fuge J, Vonberg RP, Hoeper MM, Welte T, et al. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19. Infection. 2021;49:935\u201343. https:\/\/doi.org\/10.1007\/s15010-021-01615-8.","journal-title":"Infection"},{"key":"9173_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jacamr\/dlab180","volume":"3","author":"R Houghton","year":"2021","unstructured":"Houghton R, Moore N, Williams R, El-Bakri F, Peters J, Mori M, et al. C-reactive protein-guided use of procalcitonin in COVID-19. JAC-Antimicrobial Resist. 2021;3:1\u20135. https:\/\/doi.org\/10.1093\/jacamr\/dlab180.","journal-title":"JAC-Antimicrobial Resist"},{"key":"9173_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2539-x","volume":"23","author":"AC Kalil","year":"2019","unstructured":"Kalil AC, Thomas PG. Influenza Fisiopatolog\u00eda. Crit Care. 2019;23:1\u20137.","journal-title":"Crit Care"},{"key":"9173_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18073682","volume":"18","author":"WC Hong","year":"2021","unstructured":"Hong WC, Sun SF, Hsu CW, Lee DL, Lee CH. Clinical characteristics and predictors of mortality in critically ill adult patients with influenza infection. Int J Environ Res Public Health. 2021;18:1\u201314. https:\/\/doi.org\/10.3390\/ijerph18073682.","journal-title":"Int J Environ Res Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09173-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T04:02:39Z","timestamp":1710216159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09173-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9173"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09173-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3475216\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the methods were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. This study has been approved by the Investigation Committee of Son Espases University Hospital and by the Research Ethics Committee of the Balearic Islands, and a waiver of informed consent has been accepted by the Research Ethics Committee of the Balearic Islands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}